Kindred Biosciences to Provide Corporate Update

SAN FRANCISCO, Jan. 7, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will provide a corporate update via webcast on Monday, January 11, 2016 in advance of one-on-one investor meetings in San Francisco January 12-14, 2016. 

Webcast Information 

The webcast will be available on Monday, January 11, 2016 at 8:30 AM Eastern Standard Time at http://www.KindredBio.com/events and will be available for 30 days.

About Kindred Biosciences 

Kindred Biosciences is a development-stage biopharmaceutical company focused on saving and improving the lives of pets.  Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy.  The Company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats, and horses.  The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.

Contact

Denise Bevers
KindredBio
[email protected]  
(650) 701-7904

SOURCE Kindred Biosciences, Inc.

Related Links

http://www.kindredbio.com